Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Total Non-Current Liabilities came in at $103.9 million in Q1 2026, up 3.38% YoY from $100.5 million in Q1 2025, and up 0.72% on a QoQ basis from $103.1 million in Q4 2025.
Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Total Non-Current Liabilities data on file, last reported at $103.9 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 3.38% year-over-year to $103.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.9 million (up 3.38% YoY) and the FY2025 annual result came in at $103.1 million, down 1.01% from the prior year.
- Total Non-Current Liabilities rose to $103.9 million in Q1 2026, from $103.1 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $116.3 million in Q1 2024 to a low of $59.6 million in Q1 2022.
- A 5-year average of $100.7 million and a median of $103.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 135.5% — and 2025, when it retreated 13.61%.
- Tracing TMCI's Total Non-Current Liabilities over 5 years: stood at $98.5 million in 2022, then increased by 15.66% to $113.9 million in 2023, then decreased by 8.56% to $104.2 million in 2024, then slipped by 1.01% to $103.1 million in 2025, then rose by 0.72% to $103.9 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $103.9 million (Q1 2026), $103.1 million (Q4 2025), and $107.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Treace Medical Concepts | 290.12 Mn | 244.50 Mn | 35.61 Mn | 110.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 110.63 Mn |
| Mar 31, 2026 | 103.86 Mn |
| Dec 31, 2025 | 103.12 Mn |
| Sep 30, 2025 | 107.21 Mn |
| Jun 30, 2025 | 108.67 Mn |
| Mar 31, 2025 | 100.47 Mn |
| Dec 31, 2024 | 104.17 Mn |
| Sep 30, 2024 | 107.98 Mn |
| Jun 30, 2024 | 113.82 Mn |
| Mar 31, 2024 | 116.30 Mn |
| Dec 31, 2023 | 113.92 Mn |
| Sep 30, 2023 | 102.46 Mn |
| Jun 30, 2023 | 99.65 Mn |
| Mar 31, 2023 | 91.53 Mn |
| Dec 31, 2022 | 98.50 Mn |
| Sep 30, 2022 | 94.24 Mn |
| Jun 30, 2022 | 87.01 Mn |
| Mar 31, 2022 | 59.61 Mn |
| Dec 31, 2021 | 47.58 Mn |
| Sep 30, 2021 | 40.02 Mn |